Langerhans cell histiocytosis
Please note that the links contained on this search results page may take you
to sites outside of the NIH. (See Disclaimer under Site Policies for details.)
Langerhans cell histiocytosis is one of the three major classes of histiocytoses, a group of syndromes that involve an abnormal increase in the number of immune cells called histiocytes. It is suspected to be an autoimmune disease. The extra immune cells may form tumors, which can affect various parts of the body, especially the bones.[1] The underlying cause of the condition is unknown.[1][2] A variety of different factors are taken in consideration when determining the best treatment options for individuals with Langerhans cell histiocytosis.
For more information about Langerhans cell histiocytosis click on the boxes below:
Click arrows to expand or collapse a Resource Section.
Show All Resources
Hide All Resources
- More Detailed Information (Found: 5 Resources)
Links where you can find more general information, comprehensive resources, selected full text journal articles, and news updates
- General
-
MedlinePlus, a Web site designed by the National Library of Medicine Web site to help you research your health questions, provides more information about this topic. Click on the link to view this information.
-
The Merck Manuals Online Medical Library provides information on this condition. Click on the link to view the information.
-
The National Organization for Rare Disorders (NORD) is a federation of more than 130 nonprofit voluntary health organizations serving people with rare disorders. Click on the link to view information on this topic.
-
The Online Mendelian Inheritance in Man (OMIM) database contains genetics resources that discuss Langerhans cell histiocytosis. Click on the link to go to OMIM and review these resources.
-
PubMed is a searchable database of medical literature and lists journal articles that discuss Langerhans cell histiocytosis. Click on the link to view a sample search on this topic.
- Support Groups (Found: 6 Resources)
Groups providing a wide range of services, supportive resources, and information
- Umbrella Organizations
- Disease-Specific Organizations
-
Histiocytosis Association of Canada
29095 Okanagan Mission
RPO Kelowan, BC, V1W 1K2
Phone: 250-764-6104
Web site: http://www.histio.org/ca
-
Histiocytosis Association of America
72 East Holly Avenue Suite 101
Pitman, NJ 08071
Toll-free: 800-548-2758
Phone: 856-589-6606
Web site: http://www.histio.org
- Live Chat
-
The National Organization of Rare Disorders (NORD) has partnered with Inspire.com to launch an online community for people with rare diseases called The NORD Rare Disease Community. This community connects medical patients, family members, caregivers, and professionals. Click on The NORD Rare Disease Community to learn more.
-
RareShare is an online social hub dedicated to patients, families and healthcare professionals affected by rare medical disorders. Click on RareShare to learn more.
- Clinical Trials & Research (Found: 2 Resources)
Resources where you may find research studies and clinical trials
-
ClinicalTrials.gov lists trials that are studying or have studied Langerhans cell histiocytosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
-
CRISP is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other research institutions. Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies click on the link and enter the disease name in the enter search terms box and click the and button below the box. Then click Submit Query.
- Scientific Conferences (Found: 1 Resource)
Completed and upcoming scientific conferences and programs that have been sponsored by the National Institutes of Health
- Past Conferences
-
Adults with LCH - Orphans with an Orphan Disease, November 10, 2005 - November 11, 2005
Location: Royal College of Physicians, London
Description: Thanks to the energy of members of the Histiocyte Society, treatment trials in children with Langerhans Cell Histiocytosis (LCH) have been in progress since the late 1980s, but to date none have been carried out in adults.At present, therefore, there is no ‘evidence-base’ for managing adults with this disease. In the first session of this one and a half day meeting, the focus will be upon the ‘basic science’ of LCH and of normal dendritic cells; in the second session, adult and childhood LCH will be compared; and in the third, treatment options will be discussed. The final session, entitled ‘What do patients and families need?’, will embrace the views of patients, families, nurses and doctors and will conclude with recommendations about the principles of service delivery for this, and perhaps other, orphan diseases, and make specific recommendations for adults with LCH. A publication will follow shortly afterwards. The overall aim of the meeting is to highlight current deficiencies, then start to address them in the expectation that LCH in adults will soon be ‘de-orphanised’.
- NLM Gateway
A tool to search across multiple resources offered on the National Library of Medicine's Website
-
The NLM Gateway allows users to search across multiple resources offered on the National Library of Medicine's Web site. Some of these resources may be duplicated in the list of links above. Click on the link to go to the NLM Gateway, and search by condition name.